COVID-19 Exacerbates Neurovascular Uncoupling and Contributes to Endothelial Dysfunction in Patients with Mild Cognitive Impairment.

Publication date: Dec 18, 2024

Mild cognitive impairment (MCI) affects nearly 20% of older adults worldwide, with no targetable interventions for prevention. COVID-19 adversely affects cognition, with >70% of older adults with Long COVID presenting with cognitive complaints. Neurovascular coupling (NVC), an essential mechanism of cognitive function, declines with aging and is further attenuated in neurocognitive disorders. The effect of COVID-19 on NVC responses has yet to be addressed in older adults who are vulnerable to dementia progression. Participants with MCI and a history of COVID-19 (COV+, N = 31) and MCI participants with no history of infection (COV- N = 11) participated in this cross-sectional study to determine if COVID-19 affects cerebrocortical NVC responses and vascular function. Functional near-infrared spectroscopy was used to measure cerebrocortical NVC responses, and endothelial function was assessed via insonation of the brachial artery during a flow-mediated dilation protocol. NVC responses were elicited by the working memory n-back paradigm. NVC in the left dorsolateral prefrontal cortex and endothelial function was decreased in the COV+ group compared to the COV- group. These data provide mechanistic insight into how COVID-19 may exacerbate long-term cognitive sequela seen in older adults, highlighting the urgent need for further research and clinical trials to explore novel therapeutic interventions aimed at preserving/restoring NVC.

Open Access PDF

Concepts Keywords
Adults Aged
Dementia Cognitive Dysfunction
Exacerbate COVID-19
Vascular COVID-19
Cross-Sectional Studies
endothelial function
Endothelium, Vascular
Female
flow-mediated dilation
Humans
Male
Middle Aged
mild cognitive impairment
Neurovascular Coupling
neurovascular coupling
SARS-CoV-2
Spectroscopy, Near-Infrared

Semantics

Type Source Name
disease MESH COVID-19
disease MESH Mild Cognitive Impairment
disease MESH Long COVID
disease MESH neurocognitive disorders
disease MESH dementia
disease IDO history
disease MESH infection
drug DRUGBANK Ademetionine
drug DRUGBANK Coenzyme M
disease MESH lifestyle
disease MESH etiology
disease MESH cerebrovascular disease
disease IDO blood
disease MESH arterial stiffness
disease MESH abnormalities
drug DRUGBANK Sulodexide
drug DRUGBANK Oxygen
disease MESH emergency
disease IDO symptom
drug DRUGBANK Methionine
drug DRUGBANK Aspartame
drug DRUGBANK Caffeine
disease MESH hypertension
disease MESH complications
disease MESH stroke
disease MESH aphasia
disease MESH hemiparesis
disease MESH neurodegenerative diseases
pathway REACTOME Neurodegenerative Diseases
disease MESH Parkinson’s disease
disease MESH multiple sclerosis
disease MESH amyotrophic lateral sclerosis
pathway KEGG Amyotrophic lateral sclerosis
disease IDO assay
drug DRUGBANK Immune Globulin Human
drug DRUGBANK Gold
drug DRUGBANK Methylergometrine
disease MESH education level

Original Article

(Visited 1 times, 1 visits today)